Table 4 Overview of study outcomes. The number of chronic ARM users for each of the periods, including the proportion of these that receive a chronic low-value ARM prescription
| Â | 2021-Total | 2021-Low-value | % Low-value | 2022-Total | 2022-Low-value | % Low-value |
|---|---|---|---|---|---|---|
Control | 1,539 | 996 | 64.7% | 1,485 | 942 | 63.4% |
Intervention | 1,369 | 889 | 64.9% | 1,362 | 899 | 66.0% |